Search

Author/Creator Muller, Alexander J

2. Corrigendum: IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. (5th March 2019)

Authors:
Metz, Richard; Smith, Courtney; DuHadaway, James B; Chandler, Phillip; Baban, Babak; Merlo, Lauren M F; Pigott, Elizabeth; Keough, Martin P; Rust, Sonja; Mellor, Andrew L; Mandik-Nayak, Laura; Muller, Alexander J; Prendergast, George C
Journal:
International immunology
Issue:
Volume 31:Number 3(2019)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. (5th March 2019)

Authors:
Metz, Richard; Smith, Courtney; DuHadaway, James B; Chandler, Phillip; Baban, Babak; Merlo, Lauren M F; Pigott, Elizabeth; Keough, Martin P; Rust, Sonja; Mellor, Andrew L; Mandik-Nayak, Laura; Muller, Alexander J; Prendergast, George C
Journal:
International immunology
Issue:
Volume 31:Number 3(2019)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. Issue 2 (20th July 2020)

Authors:
Dey, Souvik; Sutanto-Ward, Erika; Kopp, Katharina L; DuHadaway, James; Mondal, Arpita; Ghaban, Dema; Lecoq, Inés; Zocca, Mai-Britt; Merlo, Lauren M F; Mandik-Nayak, Laura; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Muller, Alexander J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗